gadofosveset

DRUG3 trials

Sponsors

Stanford University, Duke University, Paul Finn

Conditions

CancerHealthyPediatric Congenital Heart Disease

Phase 2

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

CompletedNCT00375830

Stanford UniversityCancer

Start: 2006-01-31End: 2019-03-14Updated: 2023-12-12

Phase 4

Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease

CompletedNCT02752191

Paul FinnPediatric Congenital Heart Disease

Start: 2016-04-30End: 2018-12-19Updated: 2022-12-28

Unknown Phase

Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants

CompletedNCT01431300

Duke UniversityHealthy

Start: 2011-08-31End: 2013-07-31Updated: 2013-12-10

Related Papers

Four-dimensional Multiphase Steady-State MRI with Ferumoxytol Enhancement: Early Multicenter Feasibility in Pediatric Congenital Heart Disease

Radiology2021-04-2033 citations

Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose.

2013-09-016 citations